Skip to content

Webinar: The New Health Data Laws Every Retailer Must Know

November 12, 2025
1:00 PM - 2:00 PM ET

State laws like Washington’s My Health My Data Act and Nevada’s SB 370 are redefining what counts as health data—casting a wide net over common retail signals such as location, browsing behavior, loyalty IDs, and ad tags when linked to sensitive topics like pregnancy, fertility, contraception, or even vitamins.

In this essential session, we’ll break down the fast-evolving compliance landscape, including:

  • Consent requirements
  • Geofencing bans
  • Sensitive data sale rules
  • Vendor contracting
  • California’s new ADMT/AI rules and their impact on product recommendations and fraud screening

Attendees will leave with a clear understanding of how these laws affect advertising, analytics, and data monetization as well as actionable insights for retailers on how to adapt data practices and mitigate risk in a rapidly shifting regulatory environment.

Related

Legal Updates

Texas’ Hemp THC Crackdown is Now in Effect: What Businesses Need to Know

As of Jul. 31st, Texas is enforcing tough new restrictions on hemp-derived THC products, and it’s changing the game for manufacturers, distributors, and retailers across the state. This isn’t one new law; it’s the Texas Department of State Health Services’ (DSHS) messy revival of dormant 2021 rules after a Texas Supreme Court ruling, on top of separate consumable-hemp regulations that kicked in earlier this year and are still being fought over in court. Bottom line: the rules have shifted more than once in 2026, and businesses need a clear picture of what’s banned, what’s still fine, and what’s still up in the air.

Explore more
Legal Updates

Nasdaq's $5 Million MVLS Rule Approved: What Issuers Need to Know About the Final Rule and the SEC’s Temporary Stay of Effectiveness

The SEC has approved Nasdaq’s new $5 million Market Value of Listed Securities (MVLS) continued listing standard, while temporarily staying its effectiveness pending potential Commission review. Although the final rule retains Nasdaq’s accelerated delisting framework, it expands the Nasdaq Hearings Panel’s authority to grant limited relief, giving certain issuers additional time to demonstrate compliance with Nasdaq’s more stringent initial listing standards.

Explore more
Legal Updates

Modernizing How Medicare Pays Physicians

CMS’s proposed 2027 Physician Fee Schedule modernizes Medicare payment through AI, updated practice expense data, and new reimbursement models.

Explore more